Project SeaweedSTEMCELL UNITED LIMITED(ASX:SCU) www.scu.com.sgINVESTOR DECK –Shortfall PlacementShortfall Shares at $0.009 (0.9c):Up to 168,762,521Raising up to:$1,518,862
Investment Highlights1.SCU is a plant-focused biotechnology company that produces foods and products which deliver Traditional Chinese Medicine-based health outcomes2.R&D on, and production and commercialisationof seaweeds to produce sustainable, plant-based protein foods and nutraceutical and pharmaceutical ingredients3.Proprietary technology: macroalgae seed bank; proprietary precision cultivation system; and key downstream extraction technologies4.Focus on the food, nutrition, healthcare, health supplements, cosmetics and personal care industries5.Redefining the seafood industry by using the ocean as arable land to build next generation “kelongs” (seaweed islands) harnessing natural seawater nutrition and sunlight to support seaweed cultivation6.Market focus: Singapore, Australia, Southeast Asia, and China7.Material contribution to Singapore’s 30% nutritional and food self-sufficiency by 2030 program8.Other business units include Dendrobium and Resina products, hemp-based ventures, and commercial IP licensing agreement and China-distribution agreement with Lantene
IndexOPERATIONAL ASSETS & INTELLECTUAL PROPERTY4ACHIEVEMENTS IN LAST 18 MONTHS 5BUSINESS MODEL: TABLE ILLUSTRATION 6REVENUE SOURCES/PRODUCTS 7SCU PROPRIETARY BIOTECHNOLOGIES 8KEY MARKETSSINGAPOREAUSTRALIASOUTHEAST ASIACHINASEAWEED GROWTH RATE13USE OF FUNDS AT DIFFERENT FUNDING LEVELS17DIRECTORS18
Operational Assets and Intellectual Property12345678910Research & Development facility at the Marine Aquaculture Centre on St John’s Island in Singaporepursuant to a lease with the Singapore Food Agency.Majority equity interest in joint venture company SCU-RY Farm Pte Ltd (SCU-RY), formed with joint venture partner, Rong-Yao Fisheries Pte Ltd (RYF).First 1.5 hectare “kelong” floating platform (seaweed island) established at the PulauUbin Coastal Area by SCU-RY.SCU’s existing seaweed operations on the floating platform conducted pursuant to the aquaculture licence held by RFY.SCU-RY has applied for its own aquaculture licence and is finalising the application process with the Singapore Food Agency. This will be the first seaweed cultivation licence granted in SingaporeSCU has proprietary ownership of its various biotechnologies including:MACROALGAE SEEDBANK MACROALGAE PROPRIETARY PRECISION CULTIVATION SYSTEMKEY DOWNSTREAM NUTRACEUTICAL EXTRACTION TECHNOLOGYEach seaweed island operates as a separate business unit and is therefore highly scalable.On completion of the disposal of its interest in Lantene, SCU will have:•a licence to use Lantene’s15 patents in its operations worldwide, excluding China; and•a contractual right to access and exploit Lantene’sdistribution network in China.SCU has been provided with a draft sub-lease by the Western Australian Government for two lots in the Broome Tropical Aquaculture Park.SCU has entered into a MOU with Deakin University to explore opportunities for commercial collaboration in the state of Victoria, Australia.
SCU Activity and Achievements in the past 18 Months Completion of the pilot program at St John’s Island for the commercialisation of the cultivation and harvesting of seaweeds.The formation of the joint venture company (SCU-RY) with RYF.Construction of the 1.5 hectare floating platform in the Palau Ubin Coastal Area and the commencement of cultivation of seaweeds.Advanced negotiations to obtain a lease for the 0.5 hectare site at Lim Chu Kang, including existing on-shore tanks that SCU intends to use for the cultivation of seaweed.Entering into binding minimum purchase seaweed/sea grape product sales agreement Further R&D work undertaken at the St John’s Island facility to further develop SCU’s biotechnologies.Discussions and liaison with senior levels of the Victorian and Western Australian Governments for the establishment of seaweed projects in both states.SCU has been provided with a draftsub-lease by the Western Australian Government for two lots in the BroomeTropical Aquaculture Park.
BPH Global Ltd
BPH Global Ltd (ASX:BP8) is an Asia-Pacific plant-based biotechnology company that is building a food, nutrition, healthcare, cosmetics and...
Follow News About Price Chart Annual Reports Dividends
BP8 Information
Share Price:
0.0015
24hr Change:
+0.001
24hr Change %:
+50.00%
Market Cap:
1.95M
More from BPH Global Ltd
Join Listcorp to create a personalised news feed, follow your favourite companies, save useful news, and more.
is for the purposes of raising up to$1,518,848.58 by way of the issue of168,760,953 shares in the Company together with one free attaching option for each three shares subscribed for on terms set out in the entitlement offer prospectus dated 25 July 2022. The presentation is for informational purposes only and does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase any equity, debt or other financial instruments of StemcellUnited Limited (SCU). The presentation has been prepared to assist parties in making their own evaluation and for no other purpose. Parties should furthercarry out their own due diligence. It is not intended to form the basis of any investment decision or any other decisions.No Representation or WarrantyNo representation or warranty, express or implied, is or will be givenby SCU or any of its respective affiliates, directors, officers, employees or advisers or any other person as to the accuracy or completeness of the information in this presentation or any other written, oral or other communications transmitted or otherwise made available to any party in the course of its evaluation, and no responsibility or liability whatsoever is accepted for the accuracy or sufficiency thereof or for any errors, omissions or misstatements, negligent or otherwise, relating thereto. This presentation does not purport to contain all of the information that may be required to evaluate a possible investment opportunity with respect to SCU, and does not constitute investment, tax or legal advice.The recipient also acknowledges and agrees that the information contained in this presentation is preliminary in nature and is subject to change, and any such changes may be material. SCU disclaims any duty to update the information contained in this presentation. This presentation may contain trademarks, service marks, trade names and copyrights of other companies, which are the property of their respective owners. Solely for convenience, some of the trademarks, service marks, trade names and copyrights referred to in this presentation may be listed without the TM, SM© or ® symbols, but parties assert, to the fullest extent under applicable law, the rights of the applicable owners, if any, to these trademarks, service marks, trade names and copyrights.No Offer or SolicitationThis presentation shall not constitute a solicitation of a proxy, consent or authorization with respect to any securities. This presentation shall also not constitute an offer to sell or the solicitation of an offer to buy any securities. No offer, sale or solicitation of any securities shall be made in any jurisdiction in which such offer, sale or solicitation would be prohibited. SCU does not provide investors with personal advice that any investment made will be suitable for the investor’s personal circumstances or investment objectives. No representation or warranty is given by SCU that any investment with respect to SCU is suitable for the investor or that it will meet the investor’s investment objectives.Eligible RecipientsThis presentation is provided to you as an investor to whom an offer document is not required to be given, and no registration, lodgementor other formality is required, in connection with an offer of securities. In accepting this presentation, you warrant that you are an investor within the scope of this paragraph and that you accept this presentation on the basis set out in this notice. This presentation is not, and does not constitute, or form any part of, an offer to sell or the solicitation, invitation or recommendation to purchase any securities in the United States and neither this presentation nor anything contained herein shall form the basis of any contract or commitment. The distribution of this presentation may be restricted by law. Persons who come into possession of this presentation should seek advice and observe any such restrictions. Any failure to comply with such restrictions may constitute a violation of applicable securities laws.Forward Looking StatementsThis presentation contains “forward-looking statements”. These statements are based on management’s current expectations and beliefs, as well as on a number of assumptions concerning future events. Forward-looking statements are subject to known and unknown risks and uncertainties, many of which are outside of our control and all of which could cause actual results to differ materially from the results expressed or implied in the forward-looking statements. SCU may not actually achieve the plans, intentions or expectations disclosed in these forward-looking statements and the forward-looking statements should not be unduly relied upon. We do not undertake any obligation to update forward-looking statements following the date this presentation is made.Any industry, market or other, similar data have been compiled from sources thought to be reliable, but have not been verified, and no assurance can be made as to their accuracy.RisksPlease refer to Appendix 1 for Key Risks
(20min delay)